ATE236646T1 - Reaktive sauerstoffverbindungen enthaltende verbindungen zur induzierung von zelldifferentiation maligner zellen so wie leukämie - Google Patents

Reaktive sauerstoffverbindungen enthaltende verbindungen zur induzierung von zelldifferentiation maligner zellen so wie leukämie

Info

Publication number
ATE236646T1
ATE236646T1 AT97946972T AT97946972T ATE236646T1 AT E236646 T1 ATE236646 T1 AT E236646T1 AT 97946972 T AT97946972 T AT 97946972T AT 97946972 T AT97946972 T AT 97946972T AT E236646 T1 ATE236646 T1 AT E236646T1
Authority
AT
Austria
Prior art keywords
leukemia
mammal
reactive oxygen
malignant cells
compounds
Prior art date
Application number
AT97946972T
Other languages
English (en)
Inventor
Lisa Marlene Jeffreys Smith
Original Assignee
Lisa Marlene Jeffreys Smith
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lisa Marlene Jeffreys Smith filed Critical Lisa Marlene Jeffreys Smith
Application granted granted Critical
Publication of ATE236646T1 publication Critical patent/ATE236646T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Epoxy Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT97946972T 1996-12-03 1997-12-02 Reaktive sauerstoffverbindungen enthaltende verbindungen zur induzierung von zelldifferentiation maligner zellen so wie leukämie ATE236646T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3233296P 1996-12-03 1996-12-03
PCT/CA1997/000930 WO1998024456A1 (en) 1996-12-03 1997-12-02 Reactive oxygen intermediates containing compounds effective in inducing cell differentiation of malignant cells such as leukemia

Publications (1)

Publication Number Publication Date
ATE236646T1 true ATE236646T1 (de) 2003-04-15

Family

ID=21864379

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97946972T ATE236646T1 (de) 1996-12-03 1997-12-02 Reaktive sauerstoffverbindungen enthaltende verbindungen zur induzierung von zelldifferentiation maligner zellen so wie leukämie

Country Status (7)

Country Link
US (1) US6399664B2 (de)
EP (1) EP0951288B1 (de)
AT (1) ATE236646T1 (de)
AU (1) AU5218998A (de)
CA (1) CA2274461A1 (de)
DE (1) DE69720783D1 (de)
WO (1) WO1998024456A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2377442A1 (en) * 2002-03-20 2003-09-20 Thomas Ichim Increasing tumor oxygen content by administration of stressed cells
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US7736494B2 (en) * 2003-07-31 2010-06-15 Acquisci, Inc. Ozone delivery system including a variable pitch gas-fluid contact device
US20100318014A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of acute ischemic brain stroke with ozone
US20050189302A1 (en) * 2003-07-31 2005-09-01 Latino Joseph S. Viral inactivation using ozone
WO2005025712A2 (en) * 2003-07-31 2005-03-24 Lipidviro Tech Viral inactivation using ozone
US20100316727A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of inflammatory disorders with ozone
US20100316730A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of cardiovascular diseases with ozone
JP2007507528A (ja) * 2003-10-03 2007-03-29 ボストン，ジユデイス 四量体酸素を含む方法、組成物、装置
US8777889B2 (en) 2004-06-15 2014-07-15 Ceramatec, Inc. Apparatus and method for administering a therapeutic agent into tissue
US8066659B2 (en) 2004-06-15 2011-11-29 Ceramatec, Inc. Apparatus and method for treating and dispensing a material into tissue
US7615030B2 (en) * 2003-10-06 2009-11-10 Active O, Llc Apparatus and method for administering a therapeutic agent into tissue
JP4384208B2 (ja) * 2007-07-20 2009-12-16 シャープ株式会社 外添剤の評価方法、トナーの評価方法
US20170157317A1 (en) * 2015-12-08 2017-06-08 Priya Visweswaran Balakrishnan Treatment Method to Cure Diseases Within a Patient by Administering Intravenous Oxygen Mixtures
US10335538B2 (en) * 2015-12-08 2019-07-02 Priya Visweswaran Balakrishnan System and treatment method to increase circulation and pluripotency of stem and progenitor cells within a patient

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4632980A (en) 1985-04-03 1986-12-30 Immunologics Ozone decontamination of blood and blood products
DE3940389A1 (de) * 1989-12-06 1991-06-13 Abolghassem Prof Dr M Pakdaman Therapeutisches mittel
US5622848A (en) * 1990-05-23 1997-04-22 Medical Discoveries, Inc. Electrically hydrolyzed salines as microbiocides for in vitro treatment of contaminated fluids containing blood
DE4100782A1 (de) * 1991-01-12 1992-07-16 Patentverwertung Dr J Haensler Waessrige ozonpraeparate, verfahren zu ihrer herstellung und ihre verwendung
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human

Also Published As

Publication number Publication date
CA2274461A1 (en) 1998-06-11
WO1998024456A1 (en) 1998-06-11
US20010049395A1 (en) 2001-12-06
AU5218998A (en) 1998-06-29
DE69720783D1 (de) 2003-05-15
EP0951288A1 (de) 1999-10-27
US6399664B2 (en) 2002-06-04
EP0951288B1 (de) 2003-04-09

Similar Documents

Publication Publication Date Title
ATE236646T1 (de) Reaktive sauerstoffverbindungen enthaltende verbindungen zur induzierung von zelldifferentiation maligner zellen so wie leukämie
DE60020529D1 (de) Antikörper zur krebsbehandlung und -diagnose
ES2006776A6 (es) Un procedimiento para producir una proteina il-6.
GB9415167D0 (en) Improvements relating to cancer therapy
DE69936444D1 (de) Systemische verabreichung von serum-stabilen plasmid-lipid partikeln zur krebstherapie
ATE65505T1 (de) Biologisch aktive fragmente von humanem antihaemophiliefaktor, methode zu ihrer herstellung und pharmazeutische praeparate.
ES2102196T3 (es) Periferializacion de celulas pluripotenciales hematopoyeticas.
DE69332688D1 (de) Verwendung von modifiziertem c-reaktiven protein zur herstellung eines medikaments zur behandlung von krebs
ATE253117T1 (de) Adenovirus e4 proteine für induktion von zelltod
IL114382A (en) Lymphotoxin for use as a medicament for cancer therapy and use thereof in the manufacture of such medicament
AU5827080A (en) 6-substituted-11-alkylene morphanthridines
DE3879575D1 (de) Alpha-carotin zur wachstumshemmung von krebszellen.
ES2012547A6 (es) Procedimiento para preparar una composicion farmaceutica que contiene metaloporfirinas.
ES8603270A1 (es) Procedimiento para preparar liposomas que contiene alergenoso fracciones de alergenos inhalables
GB2226494B (en) Photosynthesis in men's blood to cure cancer-part 2 phmd(cancer)
HU900525D0 (en) Process for the production of medical preparations for treating endotoxinemy
GB2185017A (en) Seco-sterol compounds effective in inducing the differentiation of malignant cells
GB2213373B (en) Po-man's photosynthesis in men's blood to cure cancer (phmdcc)
SE8604587D0 (sv) Lekemedelssats for sarlekningsstimulering samt sett att anvenda och tillverka satsen
EP0136093A3 (de) Antikrebsfaktoren
IT1274592B (it) Composizione farmaceutica per la terapia tumorale contenente xenoantigeni
RU96102282A (ru) Способ терапии поллиноза
NZ506005A (en) Recombinant proteins derived from hgf and msp
ES2165366T3 (es) Procedimientos y composiciones para inhibir la inflamacion mediada por celulas endoteliales y fibrinogeno.
UA19109A (uk) Спосіб посилеhhя протилейкозhої активhості циклофосфаhу

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties